ReviewAdvances in experimental medicine and biology2026
The Role of the Hedgehog Pathway in Alcohol-Induced Birth Defects.
Review in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this chapter, we review the current literature that focuses on the role of Sonic hedgehog (Shh) signaling, a major morphogenic pathway regulating embryonic development, in the pathology of fetal alcohol spectrum disorder (FASD), caused by prenatal alcohol exposure (PAE). Ethanol exposure disrupts Shh signaling during development across a range of species including in mice, chick, and zebrafish. Ethanol appears to interfere with Shh signaling through multiple mechanisms, both direct and indirect, including reduced Shh ligand production, impaired post-translational processing, and inducing apoptosis in Shh-expressing cells during gastrulation. These disruptions result in a spectrum of developmental defects characteristic of FASD, such as craniofacial abnormalities, brain malformations, and limb deformities. Genetic susceptibility to PAE is linked to mutations in Shh pathway components. Activation of Shh signaling, genetically or pharmacologically, has been effective in mitigating ethanol-induced defects. This chapter also examines the teratogenic effects of cannabinoids (CBs) and ethanol, which synergistically disrupt Shh signaling. CBs directly interact with Smoothened, a key Shh receptor, amplifying developmental defects when combined with ethanol exposure. This chapter details the critical role of Shh signaling in embryogenesis and its vulnerability to environmental teratogens such as ethanol and CBs.
Indexed as
Identifiers
41478918What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.